BROSSARD, Quebec, Jan. 17, 2018 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, “the Corporation” or “we”) (TSX
VENTURE:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its
FLAIRE platform based on Artificial Intelligence (AI), announces today
that it will implement a medical blockchain protocol for security control of medical records
The Corporation believes it is well-suited to seize this market opportunity and become a leader in this field
based on its experienced AI team, which has been developing applications for the last 15 years using its Artificial Intelligence
platform CARA. The Corporation has comprehensive domain expertise and understanding of the digital healthcare marketplace and can
rely on an experienced team with a proven track-record of delivering and implementing large-scale projects, and scaling healthcare
businesses internationally.
"DIAGNOS is currently implementing a blockchain technology for its CARA platform to securely store patients’
health data and share electronic medical records with our customers such as governments, hospitals, doctors and other health
specialists. Medical data will be securely stored on a trusted distributed ledger," said Mr. André Larente, President of
DIAGNOS.
In 2017, Crypto currency was the main focus of application for blockchain technology. Bitcoin, Ethereum and
other currencies took most of the market’s attention. The focus has begun to shift to an array of non-financial use cases spanning
across healthcare, identity and authentication, telecoms, media, and supply chain management, among others, according to BIS
Research, a global market intelligence, research and advisory company which focuses on those emerging trends in technology which
are likely to disrupt the dynamics of the market over the next five (or ten) years. Also according to BIS Research, healthcare
organizations are expected to begin the process from pilot tests towards implementation of blockchain near the end of the year,
highlighting that some of the biggest use cases behind adapting the technology include maintaining records of credentials and
licenses, data exchange to enhance patient care, population health management and medical monitoring.
About DIAGNOS and its technologies
DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging, text
and traditional data mining. DIAGNOS has developed its own Artificial Intelligence (“AI”) technologies, CARA and
FLAIRE. FLAIRE is a powerful AI
engine that provides the capability of analyzing large and complex data sets. Using Deep Learning methodology combined with
our own proprietary algorithms we can deploy rapidly new solutions to the healthcare market.
Additional information on DIAGNOS is available at www.diagnos.ca and www.sedar.com.
For further information, please contact:
Mr. André Larente, President
DIAGNOS Inc.
Tel: 450-678-8882 ext. 224
alarente@diagnos.ca
Daniel Renaud or Thomas Renaud, Managing Directors
Arrowhead Business and Investment Decisions, LLC
Tel: +1 212 619 6889, ext. 7010
diagnos@arrowheadbid.com
This news release contains forward-looking information. There can be no assurance that forward-looking
information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these
statements. DIAGNOS disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as
a result of new information, future events or otherwise. The forward-looking information contained in this news release is
expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
